Literature DB >> 11158349

Construction and analysis of ss-lactamase-inhibitory protein (BLIP) non-producer mutants of Streptomyces clavuligerus.

Wendy Thai1, Ashish S Paradkar1, Susan E Jensen1.   

Abstract

The gene encoding BLIP, a beta-lactamase-inhibitory protein, was disrupted in wild-type Streptomyces clavuligerus and in a clavulanic acid non-producing mutant. The resulting BLIP mutant and BLIP/clavulanic acid double mutant showed no residual proteinaceous beta-lactamase-inhibitory activity, indicating that only a single beta-lactamase-inhibitory protein exists in S. clavuligerus. The lack of any proteinaceous beta-lactamase-inhibitory activity in the bli and bli/claR mutants also indicates that BLP, the BLIP-like protein, encoded by S. clavuligerus does not possess beta-lactamase-inhibitory activity despite its similarity to BLIP. The bli mutant and the bli/claR double mutant did not show any aberrant growth morphology, sporulation defects, or alterations in cephamycin C production or penicillin G resistance when compared to wild-type S. clavuligerus or to the claR single mutant. Mutants bearing the bli gene disruption did show an elevated level of production of clavam-2-carboxylate and hydroxymethyl clavam as well as clavulanic acid. This phenomenon was observed in the middle stages of production of these clavams but was not detected during maximum production. The production of BLIP was also determined to be down-regulated in a ccaR mutant, lacking the pathway-specific transcriptional regulator required for production of cephamycin C and clavulanic acid. Sequencing of the regions flanking the bli gene showed the presence of a partial open reading frame that encodes a DNA-binding protein, and several open reading frames apparently involved in the production of an ABC transporter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158349     DOI: 10.1099/00221287-147-2-325

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  7 in total

1.  Five additional genes are involved in clavulanic acid biosynthesis in Streptomyces clavuligerus.

Authors:  S E Jensen; A S Paradkar; R H Mosher; C Anders; P H Beatty; M J Brumlik; A Griffin; B Barton
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase.

Authors:  Ji Yuan; Dar-Chone Chow; Wanzhi Huang; Timothy Palzkill
Journal:  J Mol Biol       Date:  2011-01-13       Impact factor: 5.469

3.  Fine mapping of the sequence requirements for binding of beta-lactamase inhibitory protein (BLIP) to TEM-1 beta-lactamase using a genetic screen for BLIP function.

Authors:  Ji Yuan; Wanzhi Huang; Dar-Chone Chow; Timothy Palzkill
Journal:  J Mol Biol       Date:  2009-04-21       Impact factor: 5.469

4.  The paralogous pairs of genes involved in clavulanic acid and clavam metabolite biosynthesis are differently regulated in Streptomyces clavuligerus.

Authors:  Kapil Tahlan; Cecilia Anders; Susan E Jensen
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

5.  Transcriptomic analysis of Streptomyces clavuligerus ΔccaR::tsr: effects of the cephamycin C-clavulanic acid cluster regulator CcaR on global regulation.

Authors:  R Alvarez-Álvarez; A Rodríguez-García; I Santamarta; R Pérez-Redondo; A Prieto-Domínguez; Y Martínez-Burgo; P Liras
Journal:  Microb Biotechnol       Date:  2014-01-22       Impact factor: 5.813

6.  In vivo functional analysis of a class A β-lactamase-related protein essential for clavulanic acid biosynthesis in Streptomyces clavuligerus.

Authors:  Santosh K Srivastava; Kelcey S King; Nader F AbuSara; Chelsea J Malayny; Brandon M Piercey; Jaime A Wilson; Kapil Tahlan
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

7.  Comparative Genomics and Metabolomics Analyses of Clavulanic Acid-Producing Streptomyces Species Provides Insight Into Specialized Metabolism.

Authors:  Nader F AbuSara; Brandon M Piercey; Marcus A Moore; Arshad Ali Shaikh; Louis-Félix Nothias; Santosh K Srivastava; Pablo Cruz-Morales; Pieter C Dorrestein; Francisco Barona-Gómez; Kapil Tahlan
Journal:  Front Microbiol       Date:  2019-11-08       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.